Charles Maurer, MD, is highly regarded for his compassion and interaction with his patients. His philosophy in treating his patients is rooted in the importance of communication. He is board certified in medical oncology, and hematology. In addition he serves as the Mary Washington Cancer Committee Chairman and director of the Mary Washington Oncology Executive Committee.
Dr. Maurer received his MD from SUNY Health Science Center at Syracuse in New York, and completed his fellowship in hematology and medical oncology at the University of Rochester Strong Memorial Hospital in Rochester, New York.
Ricky Newton, CPA, is the director for Cancer Specialists of Tidewater, Ltd., and has been on the board of the Community Oncology Alliance since its inception in 2002, currently serving as its director of financial services and operations. Ricky has more than 28 years of experience in the healthcare industry; he is the creator and manager of the community oncology pharmacy association and the COAnalyzer benchmarking software for COA.
Ricky has presented and consulted at over 350 conferences and practices in 46 states on topics such as financial and practice management issues in medical practices, healthcare law, relationships between oncologists and hospitals, employee management, and compensation models. Ricky serves as treasurer of Oncology Managers and the National Oncology Society Network.
Thomas A. Gallo, MS, MDA, is executive director of the Virginia Cancer Institute in Richmond, Virginia. In this role, he manages all aspects of a 24-provider medical oncology practice with 7 medical offices, ambulatory infusion centers, laboratories, and more than 200 employees. Among his responsibilities are strategic planning, operations, financial management, personnel management, and purchasing.
Mr. Gallo has been an active member of the Association of Community Cancer Centers (ACCC) for more than 10 years. He served as ACCC President-Elect 2017-2018. Currently, he also serves on ACCC’s Governmental Affairs Committee, which he previously chaired. He has presented at a number of ACCC Annual Meetings and has previously served on the ACCC Board of Trustees (2004-2005).
In addition to his involvement with ACCC, Mr. Gallo is a member of the Board of Directors of MD Value Care, an ACO of independent physician practices; past president of the Executive Committee of the MGMA Administrators in Oncology-Hematology Assembly (AOHA); a current member and former president of the Board of Directors of the Virginia Association of Hematologists and Oncologists (VAHO); and a former board member of the Community Oncology Alliance.
Prior to entering the healthcare field, Mr. Gallo was a commercial banker with Marine Midland Bank in New York City and Central Fidelity Bank in Richmond, Virginia.
He received a BA in Economics from the College of William and Mary in Williamsburg, Virginia, and an MS in Finance and a Master of Decision Analytics (MDA) degree from Virginia Commonwealth University, where he was a Dean’s Scholar.
James May III, MD, FACP, has more than 30 years of experience in oncology, and is known for his accessibility, trustworthiness, and commitment. Dr. May has greatly contributed to VCI’s reputation for excellence and empathy. Currently, he serves as secretary and managing partner and has also held many other important positions, including vice chairman of Johnston-Willis Hospital’s oncology department and medical director of its hospice program.
Dr. May obtained his MD from Virginia Commonwealth University School of Medicine, where he continued to complete his residency. Dr. May boasts membership in many local and national organizations including the American College of Physicians, the Academy of Hospice Physicians, the American Society of Clinical Oncology, the Richmond Academy of Medicine, the Southwest Oncology Group, and the Medical Society of Virginia.
His talents and interests lie in geriatric oncology and palliative care. His treatment philosophy emphasizes that quality of life is crucial to improving all aspects of life with cancer.
Amy K. Skorupa, MD, earned her medical degree from the Medical College of Virginia, and completed an internal medicine residency at the Medical University of South Carolina in Charleston, where she remained to complete fellowship training in hematology and oncology. She is board certified by the American Board of Internal Medicine in internal medicine and the subspecialties of hematology and medical oncology.
A skilled, compassionate oncologist and hematologist, Dr. Skorupa chose her medical specialties because of the close relationships she is able to develop with patients due to the frequency of care needed. With honesty as one of her most prominent core values, she is committed to giving her patients the care and concern they deserve. Her medical practice is also based on the philosophy that a team approach is the best way to care for a patient.
Christopher N. Vaughn, MD, has a special interest in breast cancer, lung cancer, and lymphoma and values his interactions with each of his oncology patients. During his career, Dr. Vaughn has been a guest presenter at numerous conferences, lending his expertise on the current approaches in cancer therapy, especially his enthusiasm to adopt new targeted and immunologic therapies to continue the advancement of quality personalized oncology care.
Board certified in medical oncology, hematology, and internal medicine, Dr. Vaughn earned a medical degree from Medical University of South Carolina. He completed a residency in internal medicine at the University of Virginia School of Medicine and his fellowship in hematology and oncology at the University of Virginia School of Medicine.
Dr. Vaughn has been affiliated with several professional medical organizations, including the Division of Hematology & Oncology-University of Virginia School of Medicine, the American Society of Clinical Oncology, and the American Society of Hematology. He continues to serve an active role in the medical community as a cancer committee chair at Spotsylvania Regional Medical Center, malignant hematology service chair at Mary Washington Hospital, and clinical trials principal investigator.